Display options
Cite
Richert L, Uebelhart B, Engelhardt M, et al. A randomized double-blind placebo-controlled trial to investigate the effects of nasal calcitonin on bone microarchitecture measured by high-resolution peripheral quantitative computerized tomography in postmenopausal women - study protocol. Trials. 2008;9:19doi: 10.1186/1745-6215-9-19.
Richert, L., Uebelhart, B., Engelhardt, M., Azria, M., & Rizzoli, R. (2008). A randomized double-blind placebo-controlled trial to investigate the effects of nasal calcitonin on bone microarchitecture measured by high-resolution peripheral quantitative computerized tomography in postmenopausal women - study protocol. Trials, 919. https://doi.org/10.1186/1745-6215-9-19
Richert, Laura, et al. "A randomized double-blind placebo-controlled trial to investigate the effects of nasal calcitonin on bone microarchitecture measured by high-resolution peripheral quantitative computerized tomography in postmenopausal women - study protocol." Trials vol. 9 (2008): 19. doi: https://doi.org/10.1186/1745-6215-9-19
Richert L, Uebelhart B, Engelhardt M, Azria M, Rizzoli R. A randomized double-blind placebo-controlled trial to investigate the effects of nasal calcitonin on bone microarchitecture measured by high-resolution peripheral quantitative computerized tomography in postmenopausal women - study protocol. Trials. 2008 Apr 13;9:19. doi: 10.1186/1745-6215-9-19. PMID: 18405390; PMCID: PMC2373283.
Copy Download .nbib Format: NLM
Share it on

Trials. 2008 Apr 13;9:19. doi: 10.1186/1745-6215-9-19.

A randomized double-blind placebo-controlled trial to investigate the effects of nasal calcitonin on bone microarchitecture measured by high-resolution peripheral quantitative computerized tomography in postmenopausal women - study protocol.

Trials

Laura Richert, Brigitte Uebelhart, Marc Engelhardt, Moise Azria, René Rizzoli

Affiliations

  1. Service of Bone Diseases, Department of Rehabilitation and Geriatrics, University Hospitals of Geneva, 24, Rue Micheli-du-Crest, 1211 Geneva 14, Switzerland. [email protected]

PMID: 18405390 PMCID: PMC2373283 DOI: 10.1186/1745-6215-9-19

Abstract

BACKGROUND: Bone microarchitecture is a significant determinant of bone strength. So far, the assessment of bone microarchitecture has required bone biopsies, limiting its utilization in clinical practice to one single skeletal site. With the advance of high-resolution imaging techniques, non-invasive in vivo measurement of bone microarchitecture has recently become possible. This provides an opportunity to efficiently assess the effects of anti-osteoporotic therapies on bone microarchitecture. We therefore designed a protocol to investigate the effects of nasal salmon calcitonin, an inhibitor of osteoclast activity, on bone microarchitecture in postmenopausal women, comparing weight bearing and non-weight bearing skeletal sites.

METHODS: One hundred postmenopausal women will be included in a randomized, placebo-controlled, double-blind trial comparing the effect of nasal salmon calcitonin (200 UI/day) to placebo over two years. Bone microarchitecture at the distal radius and distal tibia will be determined yearly by high-resolution peripheral quantitative computerized tomography (p-QCT) with a voxel size of 82 mum and an irradiation of less than 5 muSv. Serum markers of bone resorption and bone formation will be measured every 6 months. Safety and compliance will be assessed. Primary endpoint is the change in bone microarchitecture; secondary endpoint is the change in markers of bone turnover.

HYPOTHESIS: The present study should provide new information on the mode of action of nasal calcitonin. We hypothezise that - compared to placebo - calcitonin impacts on microstructural parameters, with a possible difference between weight bearing and non-weight bearing bones.

TRIAL REGISTRATION: ClinicalTrials.gov NCT00372099.

References

  1. Osteoporos Int. 2002;13(2):97-104 - PubMed
  2. Bone. 1991;12(2):99-105 - PubMed
  3. J Clin Endocrinol Metab. 2005 Dec;90(12):6508-15 - PubMed
  4. N Engl J Med. 2006 May 25;354(21):2250-61 - PubMed
  5. Am J Med. 2000 Sep;109(4):267-76 - PubMed
  6. Bone. 1996 Mar;18(3):215-20 - PubMed
  7. Osteoporos Int. 2003;14 Suppl 3:S13-8 - PubMed
  8. Calcif Tissue Int. 1997 Feb;60(2):164-70 - PubMed
  9. J Bone Miner Res. 2005 Sep;20(9):1548-61 - PubMed
  10. Bone. 1999 Jan;24(1):35-9 - PubMed
  11. Bone. 1996 Feb;18(2):207-12 - PubMed
  12. J Bone Miner Res. 1996 Oct;11(10):1531-8 - PubMed
  13. Calcif Tissue Int. 1992 Apr;50(4):381-3 - PubMed
  14. BMJ. 1992 Sep 5;305(6853):556-61 - PubMed

Publication Types